Amgen/AstraZeneca Say Asthma Drug Shows Activity In Another Lung Disease Across Broad Patient Population

Sunday, Amgen Inc (NASDAQ:AMGN) and AstraZeneca Plc (NASDAQ:AZN) announced the results of the Phase 2a COURSE trial of Tezspire (tezepelumab-ekko) for severe chronic obstructive pulmonary disease (COP

Benzinga13:38

AstraZeneca, Amgen Release Mid-stage Data on Tezspire for COPD

Seeking Alpha11:49

Novavax Says Distribution Of R21/Matrix-MTM Across The African Region Is Expected To Begin In Coming Weeks

Novavax Says Distribution Of R21/Matrix-MTM Across The African Region Is Expected To Begin In Coming Weeks

BenzingaMay 20 10:48

Witness history! The Dow closed above 40,000 points for the first time. Apart from constituent stocks, these ETFs are also worth watching

Buffett once said, “By regularly investing in index funds, an amateur investor who doesn't understand anything can often beat most professional investors.”

Futu NewsMay 20 06:05

Reported Sunday, AstraZeneca And Amgen's TEZSPIRE Shows Potential For Future Chronic Obstructive Pulmonary Diseasetreatment In New Data Presented At ATS 2024

Late-breaking results from the Phase IIa COURSE trial provide insight into TEZSPIRE's impact on COPD exacerbations in patients with a broad range of eosinophil levelsThe Phase IIa COURSE trial was a p

BenzingaMay 19 23:55

Cannabis Meets Prescription Drugs, Steroids And Ketamine In Schedule III: What It Means, Key Stocks To Watch

President Joe Biden's administration is moving to reschedule cannabis from Schedule I to Schedule III under the Controlled Substances Act (CSA). This shift could revolutionize the cannabis industry. B

BenzingaMay 18 09:19